3rd LNP Characterization and Analytical Development Summit
November 18 - 20, 2025 - MA USHanson Wade
info@hansonwade.com
Phone:+1 617 455 4188
LNPs continue to dominate as the non-viral delivery vehicle of choice given their ability to encapsulate fragile payloads, such as mRNA, siRNA, gRNA and more, and deliver them into target cells with high efficacy. However, critical challenges remain in assessing targeted LNP surface functionalization, evaluating encapsulation efficiency for multivalent formulations, and aligning analytical results with process performance. The 3rd LNP Characterization and Analytical Development Summit is the only global event dedicated to this specialized field, providing analytical experts with in-depth technical insights into accelerating development timelines, overcoming analytical gaps and streamlining regulatory submissions for fast-tracking approval of high-quality LNP drug products. Join experts from Pfizer, Novo Nordisk, Prime Medicine, Tessera Therapeutics, GSK, Sanofi, and more as we explore the cutting edge of LNP characterization and analytics. Don’t miss this opportunity to collaborate with the brightest minds shaping the future of LNP drug development. Time: 7:30 AM - 4:30 PM